Form 4 Filing for Jamie L. Reynoso

This filing details a Form 4 submission by Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments Corp. On April 1, 2026, Reynoso acquired 159,384 shares of Class A Common Stock with a transaction price of $0.00. These shares are underlying a time-based restricted stock unit award. The award vests in stages: 25% on the first anniversary of April 1, 2026, and the remainder in equal quarterly installments thereafter, fully vesting by April 1, 2030, contingent upon continued service. Following this transaction, Reynoso holds 2,876,119 shares. The filing was signed on April 3, 2026, by Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso.